The Association of Clinical Research Professionals (ACRP) has responded to the editors of The Toronto Star in regard to its recent news and editorial coverage of Health Canada and the pharmaceutical industry in Canada.
The Association of Clinical Research Professionals (ACRP) has responded to the editors of The Toronto Star in regard to its recent news and editorial coverage of Health Canada and the pharmaceutical industry in Canada. The letter takes issue with the way the news coverage mischaracterizes and sensationalizes Health Canada's relationship with pharmaceutical companies. In addition, ACRP's Deputy Executive Director Terri Hinkley, maintains that its "inaccurate picture for the public that unnecessarily and irresponsibly cultivates distrust, discourages trial participation, and by default casts an underserved shadow on the thousands of dedicated professionals, fellow Canadians, who conduct clinical trials responsibly and ethically."
Soon after the article was published, other Canadian clinical trials experts aired their own opinions of the Star's portrayal.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.